Greykasell Wealth Strategies’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24K Hold
79
﹤0.01% 414
2026
Q1
$6.81K Hold
79
﹤0.01% 444
2025
Q4
$6.9K Hold
79
﹤0.01% 391
2025
Q3
$4.52K Hold
79
﹤0.01% 344
2025
Q2
$4.66K Hold
79
﹤0.01% 281
2025
Q1
$5.78K Buy
+79
New +$6.53K ﹤0.01% 292

Other funds holding GMED

Greykasell Wealth Strategies's GMED Position: Q2 2026 in Review

Greykasell Wealth Strategies held its Globus Medical (GMED) position steady in Q2 2026 at 79 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

Greykasell Wealth Strategies first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.9K in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Greykasell Wealth Strategies held 79 shares of Globus Medical worth $6.24K as of Q2 2026.
  • Greykasell Wealth Strategies left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #414 holding.
  • Greykasell Wealth Strategies first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • Greykasell Wealth Strategies's Globus Medical position peaked at $6.9K in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.